A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

por Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., Peterse, J.
Publicado 1996

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

por Meijnen, P, Peterse, J L, Antonini, N, Rutgers, E J Th, van de Vijver, M J
Publicado 2008

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

por Faneyte, I F, Schrama, J G, Peterse, J L, Remijnse, P L, Rodenhuis, S, van de Vijver, M J
Publicado 2003

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

por Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E
Publicado 2003

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

por Bijker, N, Peterse, J L, Fentiman, I S, Julien, J-P, Hart, A A M, Avril, A, Cataliotti, L, Rutgers, E J T
Publicado 2002

Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

por Baas, P., Murrer, L., Zoetmulder, F. A., Stewart, F. A., Ris, H. B., van Zandwijk, N., Peterse, J. L., Rutgers, E. J.
Publicado 1997

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

por van der Wall, E., Rutgers, E. J., Holtkamp, M. J., Baars, J. W., Schornagel, J. H., Peterse, J. L., Beijnen, J. H., Rodenhuis, S.
Publicado 1996

Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

por Bijker, N, Peterse, J L, Duchateau, L, Robanus-Maandag, E C, Bosch, C A J, Duval, C, Pilotti, S, van de Vijver, M J
Publicado 2001

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

por Vos, C B J, Haar, N T ter, Rosenberg, C, Peterse, J L, Cleton-Jansen, A-M, Cornelisse, C J, Vijver, M J van de
Publicado 1999

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

por Tanis, P J, Nieweg, O E, Valdés Olmos, R A, Peterse, J L, Rutgers, E J Th, Hoefnagel, C A, Kroon, B B R
Publicado 2002

Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions

por Pijnappel, R M, van den Donk, M, Holland, R, Mali, W P Th M, Peterse, J L, Hendriks, J H C L, Peeters, P H M
Publicado 2004

No common denominator for breast cancer lymph node metastasis

por Weigelt, B, Wessels, L F A, Bosma, A J, Glas, A M, Nuyten, D S A, He, Y D, Dai, H, Peterse, J L, van't Veer, L J
Publicado 2005

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.

por Vos, C. B., Cleton-Jansen, A. M., Berx, G., de Leeuw, W. J., ter Haar, N. T., van Roy, F., Cornelisse, C. J., Peterse, J. L., van de Vijver, M. J.
Publicado 1997